La cadena de opciones muestra datos clave de las opciones de acciones de Monopar Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Monopar Therapeutics..

Monopar Therapeutics (NASDAQ:MNPR) Bolsa, Cadena de Opciones

MONOPAR THERAPEUTICS INC

Monopar Therapeutics

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Monopar Therapeutics Inc

Analyst Ratings

Press Releases

Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics

Earnings

Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments

Health Care

Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments

Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

General

Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers

Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments

MNPR

AC Immune

Alector

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Caribou Biosciences

Cargo Therapeutics

enGene Holdings

Eupraxia Pharmaceuticals Inc. - Common Stock

Eupraxia Pharmaceuticals

Fennec Pharmaceuticals Inc. - Common Stock

Fennec Pharmaceuticals

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Genfit

Heron Therapeutics

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Korro Bio

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Lyell Immunopharma

ProQR Therapeutics N.V. - Ordinary Shares

ProQR Therapeutics

RAPT Therapeutics

Instil Bio

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Tevogen Bio Holdings

Voyager Therapeutics, Inc. - Common Stock

Comments

Monopar Therapeutics

Monopar Therapeutics (MNPR) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL